Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marko Poglitsch

Showing results (71-80 of 82) with videos related to

Pageof 9
Sort By:
Journal of the American Heart Association|January 30, 2015
Vitamin D depletion aggravates hypertension and target-organ damageLouise Bjørkholt Andersen, Lukasz Przybyl, Nadine Haase, et al.
British Journal of Pharmacology|September 15, 2022
Blood pressure-independent renoprotective effects of small interference RNA targeting liver angiotensinogen in experimental diabetesEdwyn O Cruz-López, Liwei Ren, Estrellita Uijl, et al.
Circulation Research|May 19, 2020
Critical Role of Neprilysin in Kidney Angiotensin MetabolismChristopher C Kaltenecker, Oliver Domenig, Chantal Kopecky, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 14, 2019
Apelin protects against abdominal aortic aneurysm and the therapeutic role of neutral endopeptidase resistant apelin analogsWang Wang, Mengcheng Shen, Conrad Fischer, et al.
Scientific Reports|September 22, 2016
Neprilysin is a Mediator of Alternative Renin-Angiotensin-System Activation in the Murine and Human KidneyOliver Domenig, Arndt Manzel, Nadja Grobe, et al.
Hypertension (Dallas, Tex. : 1979)|March 15, 2021
Renoprotective Effects of Small Interfering RNA Targeting Liver Angiotensinogen in Experimental Chronic Kidney DiseaseDominique M Bovée, Liwei Ren, Estrellita Uijl, et al.
Kidney International|April 2, 2015
Optimum AT1 receptor-neprilysin inhibition has superior cardioprotective effects compared with AT1 receptor blockade alone in hypertensive ratsLodi C W Roksnoer, Richard van Veghel, René de Vries, et al.
Hypertension (Dallas, Tex. : 1979)|April 12, 2017
Brain Renin-Angiotensin System: Does It Exist?Bibi S van Thiel, Alexandre Góes Martini, Luuk Te Riet, et al.
Scientific Reports|October 13, 2019
Retinoic acid receptor α as a novel contributor to adrenal cortex structure and function through interactions with Wnt and Vegfa signallingRami M El Zein, Audrey H Soria, Jose Felipe Golib Dzib, et al.
Hypertension (Dallas, Tex. : 1979)|July 15, 2024
Progressive Kidney Failure by Angiotensinogen Inactivation in the GermlineFlorian J Wopperer, Eric Olinger, Antje Wiesener, et al.
Pageof 9

Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
Journal of the American Heart Association|January 30, 2015
Vitamin D depletion aggravates hypertension and target-organ damageLouise Bjørkholt Andersen, Lukasz Przybyl, Nadine Haase, et al.
British Journal of Pharmacology|September 15, 2022
Blood pressure-independent renoprotective effects of small interference RNA targeting liver angiotensinogen in experimental diabetesEdwyn O Cruz-López, Liwei Ren, Estrellita Uijl, et al.
Circulation Research|May 19, 2020
Critical Role of Neprilysin in Kidney Angiotensin MetabolismChristopher C Kaltenecker, Oliver Domenig, Chantal Kopecky, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 14, 2019
Apelin protects against abdominal aortic aneurysm and the therapeutic role of neutral endopeptidase resistant apelin analogsWang Wang, Mengcheng Shen, Conrad Fischer, et al.
Scientific Reports|September 22, 2016
Neprilysin is a Mediator of Alternative Renin-Angiotensin-System Activation in the Murine and Human KidneyOliver Domenig, Arndt Manzel, Nadja Grobe, et al.
Hypertension (Dallas, Tex. : 1979)|March 15, 2021
Renoprotective Effects of Small Interfering RNA Targeting Liver Angiotensinogen in Experimental Chronic Kidney DiseaseDominique M Bovée, Liwei Ren, Estrellita Uijl, et al.
Kidney International|April 2, 2015
Optimum AT1 receptor-neprilysin inhibition has superior cardioprotective effects compared with AT1 receptor blockade alone in hypertensive ratsLodi C W Roksnoer, Richard van Veghel, René de Vries, et al.
Hypertension (Dallas, Tex. : 1979)|April 12, 2017
Brain Renin-Angiotensin System: Does It Exist?Bibi S van Thiel, Alexandre Góes Martini, Luuk Te Riet, et al.
Scientific Reports|October 13, 2019
Retinoic acid receptor α as a novel contributor to adrenal cortex structure and function through interactions with Wnt and Vegfa signallingRami M El Zein, Audrey H Soria, Jose Felipe Golib Dzib, et al.
Hypertension (Dallas, Tex. : 1979)|July 15, 2024
Progressive Kidney Failure by Angiotensinogen Inactivation in the GermlineFlorian J Wopperer, Eric Olinger, Antje Wiesener, et al.
Pageof 9